sur BOIRON (EPA:BOI)
Boiron finalizes the acquisition of Hivital Labs to strengthen its e-commerce
On November 16, 2026, Boiron Laboratories announced the complete acquisition of Hivital Labs, a Spanish company specializing in food supplements. Founded in 2018, Hivital Labs offers approximately 70 health and wellness products, distributed primarily online in Spain, Germany, Italy, and France. This transaction marks a strategic turning point for Boiron, aiming to expand its presence in the food supplement and e-commerce markets.
This integration aligns with Boiron's vision implemented since 2025 and allows them to capitalize on Hivital Labs' digital expertise. Pascal Houdayer, CEO of Boiron, emphasizes the complementarity of the two companies in a shared vision of integrative healthcare. Despite this acquisition, Hivital Labs retains its autonomy, its management team, and its brand, with Ferran Forcada at its helm. The unanimous approval of the Board of Directors and the support of employees validate this transaction, financed by available cash.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de BOIRON